Australia markets close in 41 minutes

Bio-Gene Technology Limited (BGT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.07500.0000 (0.00%)
As of 04:10PM AEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
595.078
595.078
879.776
573.119
907.58
Gross profit
595.078
595.078
879.776
573.119
907.58
Operating expenses
Research development
1,979
1,979
1,899
1,676
1,444
Selling general and administrative
477.731
477.731
513.688
374.571
384.384
Total operating expenses
3,777
3,777
3,853
3,038
3,068
Operating income or loss
-3,182
-3,182
-2,974
-2,465
-2,161
Total other income/expenses net
0.25
0.25
6.478
30.966
164.549
Income before tax
-3,096
-3,096
-2,914
-2,396
-1,933
Income tax expense
0
0
0
0
0
Income from continuing operations
-3,096
-3,096
-2,914
-2,396
-1,933
Net income
-3,096
-3,096
-2,914
-2,396
-1,933
Net income available to common shareholders
-3,096
-3,096
-2,914
-2,396
-1,933
Basic EPS
-0.02
-0.02
-0.02
-0.02
-0.02
Diluted EPS
-0.02
-0.02
-0.02
-0.02
-0.02
Basic average shares
171,143
167,768
153,338
137,233
119,372
Diluted average shares
171,143
167,768
153,338
137,233
119,372